TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Area Under the Plasma Concentration-Time Curve up to Infinity (AUCinf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Combination of death and non-fatal cardiovascular events
Endpoint domain: Mortality/survival
Primary endpoint: Change in thrombin generation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: APC sensitivity ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Postoperative perception of patients
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean Plasma L-ascorbic Acid as Total Area Under the Curve [AUC(0-24 Hours)]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Leukocyte L-ascorbic Acid as Total Area Under the Curve [AUC(0-24 Hours)]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Plasma L-ascorbic Acid as Cmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Leukocyte L-ascorbic Acid as Cmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to clinical guidelines
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Participants With Peri-Dosing Adverse Events - Initial Dose
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Air Leak
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of conversion from positive to negative ctDNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: elevated intraocular pressure (IOP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Caloric Intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Social Time
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Composite score of complications
Endpoint domain: Adverse events/effects
Primary endpoint: Change in fasting serum LDL-cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Participants With Culture Negative Status by 8 Weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Nicotine Dependence Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unexpected adverse events and ADRs
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction of new HIV diagnosis
Endpoint domain: Mortality/survival
Primary endpoint: Blood pressure mean
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Visual Analog Scale (VAS) For Pain Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Procedure- or Device-related Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of Procedure- or Device-related Adverse Events (AEs) or Unanticipated Adverse Device Effects (UADEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Benign or malignant lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Bleeding phenotype
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Tumor Size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: AOFAS Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity and Specificity Threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Emotional wellbeing
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Prognosis prediction in lung cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: early postpartum hemorrhage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Sensory and motor block of the hand
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change From Baseline in Total Mayo Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Participants Who Developed a Positive Antibody Response (IgG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of Participants with and Without HSD3B1 (1245C) Germline Variant
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amniotic pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Gene Expression of Phase II Enzymes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Lipid Oxidation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: DNA Oxidation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DHT Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: 3-alpha-diol Gluconate Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Comprehension of informed consent
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: uncorrected visual acuity (UVCA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Long-term survival status
Endpoint domain: Mortality/survival
Primary endpoint: Change from baseline in Atrial Fibrillation Effect on Quality-of-Life (AFEQT) questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change from baseline in Veterans Rand (VR) 12
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of patients that experience a re-admit status post intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Sino-nasal symptom score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the presence of pathological GERD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Rate of acute exacerbations of COPD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Post-prandial glucose excursion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of subjects with PTH less than or equal to 300pg/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Mortality due to Infective Endocarditis
Endpoint domain: Mortality/survival
Primary endpoint: SCORAD area under the curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Needs of MBC patients
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Assessment of ischemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percent Change in BMD at the Lumbar Spine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Absolute change in hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Mean Change in Negative Scale Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time-to-Event
Endpoint domain: Mortality/survival
Primary endpoint: Induction Response Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fat mass and fat-free mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of Intraocular Pressure (IOP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in muscle damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in calcium cycling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Positive response to CRT treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Patients Who Achieve Therapeutic Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-operative Narcotic Use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Whole Body Insulin Sensitivity (WBISI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in pain assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in HDL fractions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in LDL fractions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: hematological and molecular remission rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: induction mortality
Endpoint domain: Mortality/survival
Primary endpoint: hematological and molecular relapse rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in Morphine Equivalent Dose (MED)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Width of angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MMT-8
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CDASI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physician's Global Disease Activity VAS Worsening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subsequent cardiovascular collapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of Participants Experiencing an Adverse Event (AE) After ProQuad® Dose 2
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants Experiencing a Vaccine-related AE After ProQuad® Dose 2
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants Experiencing a Serious AE (SAE) After ProQuad® Dose 2
Endpoint domain: Adverse events/effects
Primary endpoint: Ratio of Absolute Neutrophil Count at End of Treatment Compared to Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: St George's Respiratory Questionnaire for COPD Patients (SGRQ-C)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Hemorrhagic complication rate
Endpoint domain: Adverse events/effects
Primary endpoint: Local tumoral response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of Subject Re-arrest
Endpoint domain: Mortality/survival
Primary endpoint: Compliance of CPAP use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Improvement in Periodontal Clinical indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Social Phobia Inventory (SPIN) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Maximum (peak) steady-state plasma drug concentration (Cmax,ss)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of left ventricular ejection fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Visual grading of test site
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessments of adverse experiences
Endpoint domain: Adverse events/effects
Primary endpoint: Adjusted Mean Change From Baseline to Day 197 in Disease Activity Score (DAS) 28 Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Death, Serious Adverse Events (SAEs), Related SAEs, SAEs Leading to Discontinuation
Endpoint domain: Adverse events/effects
Primary endpoint: Mean Systolic (SBP) and Diastolic (DBP) Blood Pressure During Open Label Period
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean change in forced expiratory volume in 1 second (FEV1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of Participants With Low Cardiac Output Syndrome (LCOS) or Death
Endpoint domain: Mortality/survival
Primary endpoint: Recovery of Respiratory Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Radiographic Sternal Integrity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Sternal Revision
Endpoint domain: Adverse events/effects
Primary endpoint: Complete abortion without surgical intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EED biomarker composite score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DTG pharmacokinetic parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in coping skills
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of Local Adverse Reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Systemic Adverse Reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With Serum Hemagglutination Inhibition (HAI) Antibody Seroprotection Against Vaccine Strains Following 2-dose Vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of Participants With Serum Hemagglutination Inhibition (HAI) Antibody Seroprotection Against Vaccine Strains Following 3-dose Vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of Participants With Engraftment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Urinary Urge Incontinent (UUI) Episodes Per Day
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Eating Disorder Examination (EDE)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Boston Naming Test (BNT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: prevalence of breast milk feeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Pure Tone Audiometry (PTA) - Effective Frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distortion Product Otoacoustic Emissions (DPOAE) - DP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distortion Product Otoacoustic Emissions (DPOAE) - SNR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Middle Ear Muscle Reflex (MEMR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Speech in Noise (SiN)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tinnitus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Consistency of breast density measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in nail psoriasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Insulin sensitivity expressed as an M-value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean CPAP use hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reno-protection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in Reintegration to Normal Living Index score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Clinical improvement in mastication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of drug
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analog Score (VAS)
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Normal ovarian function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Survival of the Implant System
Endpoint domain: Mortality/survival
Primary endpoint: Successful Navigation and EGM Recording of Each Pre-specified Pulmonary Vein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of Adjudicated Serious Adverse Events Within 7 Days
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline Simple Shoulder Test (SST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time spent in target INR range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Patient Recruitment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: acute and sub-acute toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Mayo Elbow Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Veteran Rand 36 Item Health Survey (VR-36)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Patient-Related Tennis Elbow Evaluation (PRTEE)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change From Baseline in Average Pain Intensity Score - Cohort 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Average Pain Intensity Score - Cohort 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary Graft Failure
Endpoint domain: Mortality/survival
Primary endpoint: Quality of life burdens
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Neovascular Glaucoma (NVG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Children's Depression Inventory-2 (CDI-2)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Total Pain relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hypercapnia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Dose limiting toxicities of SU5416
Endpoint domain: Adverse events/effects
Primary endpoint: Duration of Induced Hypoglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Severity of Induced Hypoglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Thrombosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Total Word Reading Efficiency (TWRE)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Adalimumab Treatment Retention Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of subjects with endoscopically confirmed remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Musculoskeletal Disorders (MSDs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Symptoms reduction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Days of opioid use per week
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Area Under the Plasma Concentration-time Curve (AUC [0-24]) of abiraterone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum plasma concentration (Cmax) of abiraterone, prednisone and its metabolite prednisolone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-time Curve (AUC [0-12]) of prednisone and its metabolite prednisolone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart Rate in Daily Life
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percent Pacing in Daily Life
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart Rate on Treadmill
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Symptoms and Exercise Tolerance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mean satisfaction related to the use of cosmetics during chemotherapy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean compliance related to the use of cosmetics during chemotherapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of patients declaring skin problems after the use of these 2 cosmetics
Endpoint domain: Adverse events/effects
Primary endpoint: Hepatic Fat Fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of prevention of HCV viremia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Perioperative transfusion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: GCS (Glasgow Coma Scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: NIHSS (National Institutes of Health Stroke Scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: antisaccade error rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Bone Mineral Density of the Hip
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes